Literature DB >> 20069326

Pseudohypercalcaemia in mixed cryoglobulinaemia (IgMkappa/polyclonal IgG): a rare complication of Sjögren's syndrome.

Denise Tong1, Ari Murad, Nicholas Manolios, Graydon Howe, David Spencer.   

Abstract

This is the first reported case of pseudohypercalcaemia associated with type 2 cryoglobulinaemia, secondary to primary Sjögren's syndrome. Pseudohypercalcaemia is an asymptomatic syndrome and does not require specific treatment. However, cryoglobulins have been demonstrated to bind to calcium, affecting the cryoprecipitability, and consequently, altering the pathogenicity of the cryoglobulins. This first report highlights potential for further research into this intriguing phenomenon.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20069326     DOI: 10.1007/s10067-009-1353-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  9 in total

1.  A calcium-dependent cryoglobulin IgM kappa/polyclonal IgG.

Authors:  M Qi; G Steiger; J A Schifferli
Journal:  J Immunol       Date:  1992-10-01       Impact factor: 5.422

Review 2.  Clinical review: Rare causes of hypercalcemia.

Authors:  Thomas P Jacobs; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2005-08-30       Impact factor: 5.958

3.  Calcium binding by a myeloma protein.

Authors:  J P Jaffe; D F Mosher
Journal:  Am J Med       Date:  1979-08       Impact factor: 4.965

4.  Artefactual serum hyperkalaemia and hypercalcaemia in essential thrombocythaemia.

Authors:  M R Howard; S Ashwell; L R Bond; I Holbrook
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

5.  Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass.

Authors:  T Berney; T Fulpius; T Shibata; L Reininger; J Van Snick; H Shan; M Weigert; A Marshak-Rothstein; S Izui
Journal:  Int Immunol       Date:  1992-01       Impact factor: 4.823

Review 6.  Hypercalcemia.

Authors:  Michelle M Shepard; Jeffrey W Smith
Journal:  Am J Med Sci       Date:  2007-11       Impact factor: 2.378

7.  A human myeloma immunoglobulin G binding four moles of calcium associated with asymptomatic hypercalcemia.

Authors:  G Merlini; L A Fitzpatrick; E S Siris; J P Bilezikian; S Birken; S Beychok; E F Osserman
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

8.  Relationship of free and total calcium in hypercalcemic conditions.

Authors:  J H Ladenson; J W Lewis; J M McDonald; E Slatopolsky; J C Boyd
Journal:  J Clin Endocrinol Metab       Date:  1979-03       Impact factor: 5.958

9.  Hypercalcaemia due to calcium binding IgM paraprotein in Waldenström's macroglobulinaemia.

Authors:  L Side; M N Fahie-Wilson; M J Mills
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.